SIBANNAC, INC. CLASS A COMMON STOCK PURCHASE WARRANTSecurity Agreement • January 20th, 2022 • Sibannac, Inc. • Pharmaceutical preparations • Nevada
THIS CLASS A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______________ (the “Initial Issue Date”) and on or prior to the close of business on the two (2) year anniversary of the Initial Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Sibannac, Inc., a Nevada corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LIMITED LIABILITY COMPANY OPERATING AGREEMENT CURIDOL HOLDINGS, LLC A Member- Managed Limited Liability CompanyOperating Agreement • April 12th, 2024 • Sibannac, Inc. • Pharmaceutical preparations • Arizona
THIS OPERATING AGREEMENT is made and entered into effective June 20, 2023, by and among: Sibannac, Inc., William Charles Crosno, and Direct Global Supply, LLC (collectively referred to in this agreement as the "Members").
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 17th, 2023 • Sibannac, Inc. • Pharmaceutical preparations • Arizona
This Asset Purchase Agreement (this "Agreement") is made and entered into as of November 8, 2022, by and among SIBANNAC, INC., a Nevada corporation ("Buyer"), and NOHO, INC., a Wyoming corporation ("Seller” or “Company").
ADDENDUM TO ASSET ACQUISITION AGREEMENTAsset Acquisition Agreement • January 19th, 2016 • Sibannac, Inc. • Pharmaceutical preparations • Colorado
This ASSET ACQUISITION AGREEMENT, dated October ____, 2015 (the "Agreement"), by and among Sibannac, Inc., a Colorado Corporation, ("SI"), and Protection Cost, Inc. ("PCI"), a Colorado Corporation.
ADDENDUM TO AGREEMENT AND CONSENT WITH REPRESENTATIONS APOLLO MEDIA NETWORK, INC. AND SIBANNAC, INC.Addendum to Agreement and Consent • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations • Colorado
The Subscriber ("Subscriber") herein, as Owner of 3,100,000 shares of outstanding common stock of Apollo Media Network, Inc. (Apollo) is offering to accept in liquidation of Apollo 3,100,000 shares of the common stock of Sibannac, Inc. ("Company" or "SI"), a Colorado corporation, as contemplated under that certain Asset Acquisition Agreement dated August 19, 2015, by and between SI and Apollo (the "Acquisition Agreement").
AGREEMENT AND PLAN OF REORGANIZATIONAgreement and Plan of Reorganization • July 6th, 2017 • Sibannac, Inc. • Pharmaceutical preparations • Arizona
This Plan of Reorganization shall be reorganization within the meaning of Section 368(a)(l)(C) as amended. Purchaser shall acquire substantially all of the properties, assets and business of Seller in exchange solely for a part of Purchaser's voting common stock. As soon as practical Seller will completely liquidate and dissolve and will cause to be distributed to its shareholders, pro rata to stock ownership, all of its right, title and interest in and to the shares of Purchaser's voting common stock to be received by Seller in exchange for the surrender by shareholders for cancellation of certificates representing all of Seller's outstanding common stock.
ADDENDUM TO LOCK UP AND METERING AGREEMENTLock Up and Metering Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations
ADDENDUM TO PLEDGE AND SECURITY AGREEMENTPledge and Security Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations • Colorado
Lender is the holder of a Promissory Note dated as of June 30, 2015, made by Pledgor in favor of Apollo Media Network, Inc. (the "Note"), and subsequently transferred to Lender. It is a condition precedent to the acceptance of the Note by Lender that Pledgor shall have made the pledge contemplated by this Agreement.
Share Purchase AgreementShare Purchase Agreement • February 2nd, 2024 • Sibannac, Inc. • Pharmaceutical preparations • Arizona
This Share Purchase Agreement, dated as of March 28th, 2023 (this “Agreement”) by and among Immersive Brand Concepts, Inc., a Wyoming corporation (hereinafter referred to as “IMMERSIVE”), the shareholders of IMMERSIVE set forth on Schedule I hereto (the “IMMERSIVE Shareholders”), and Sibannac Inc., a Nevada corporation (“SNNC”), and the controlling stockholders of SNNC set forth on Schedule II hereto (the “SNNC Controlling Stockholders”).
SERVICE AND STRATEGIC PARTNERSHIP AGREEMENTService and Strategic Partnership Agreement • September 17th, 2015 • Sibannac, Inc. • Pharmaceutical preparations
This Service and Strategic Partnership Agreement (“Agreement”) is made as of August 24, 2015 (the “Effective Date”), by and between NATIONAL PEO, LLC, an Arizona limited liability company, with an address of 4800 North Scottsdale Road, Suite 2000, Scottsdale, AZ 85251 (“National”), NEXUS PARTNERS INSURANCE, LLC, an Arizona limited liability company, with an address of 4800 North Scottsdale Road, Suite 2000, Scottsdale, AZ 85251 (“Nexus”), SIBANNAC INC., a Nevada corporation, with an address of 9235 Bell Flower Way, Highlands Ranch, CO 80126 (“Sibannac”) and RIMROCK INSURANCE CONSULTING, INC., an Arizona corporation, with an address of 3033 N. Valencia Lane, Phoenix, AZ 85018 (“Rimrock”). National, Nexus, Sibannac and Rimrock are collectively referred to herein as the Parties.
ADDENDUM TO NOTE CONVERSION AGREEMENTNote Conversion Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations
ADDENDUM TO PUT OPTION AGREEMENTPut Option Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations
ADDENDUM TO ASSET ACQUISITION AGREEMENT BY AND AMONGAsset Acquisition Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations
ADDENDUM TO ASSIGNMENT, ASSUMPTION AND RELEASE AGREEMENTAssignment, Assumption and Release Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations • Arizona
This Assignment, Assumption and Release Agreement (this "Agreement") is entered into as of the 30th day of June, 2015, by and among APOLLO MEDIA NETWORK, INC., a
ADDENDUM TO EMPLOYMENT AGREEMENTEmployment Agreement • January 29th, 2016 • Sibannac, Inc. • Pharmaceutical preparations • Colorado
THIS EMPLOYMENT AGREEMENT ("Agreement") made and entered to be effective as of the 30th day of June, 2015 (the "Effective Date"), by and between Sibannac, a Colorado corporation (the "Company") and Kirk Kimerer (the "Executive").
CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENTChief Executive Officer Employment Agreement • January 20th, 2022 • Sibannac, Inc. • Pharmaceutical preparations • California
THIS CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT ("Agreement"), made effective July 10, 2017 ("Effective Date"), is by and between SIBANNAC, INC. ( the “Company”), a publicly traded company organized under the laws of the State of Nevada, doing business as SIBANNAC, INC. and DAVID MERSKY (“Mersky”).
Strategic Alliance AgreementStrategic Alliance Agreement • December 4th, 2017 • Sibannac, Inc. • Pharmaceutical preparations • Texas
This agreement is made and entered into this 30th day of November, 2017 by and between Bravatek Solutions, Inc., a corporation organized under the laws of the State of Colorado, ("Bravatek"), with an address at 2028 E. Ben White Blvd., Unit #240-2835, Austin, Texas, 78741, and Sibannac, Inc. ("COMPANY"), a corporation organized under the laws of Nevada, with an address at 2122 E Highland Avenue, Suite 425, Phoenix, Arizona 85016.
